Industry Insights by The Experts
Industry Intelligence from the Disruptors Redefining Private Label Manufacturing
What Evidence Does a Supplement Brand Need Before Making a Product Claim?
Industry: Creators, Scaling Operators, Multi-Location, Medical Groups
Why a Published Study May Not Be Enough
A supplement brand finds a promising ingredient backed by clinical research. The studies suggest potential benefits, the ingredient fits the product concept, and the marketing team begins developing claims around those findings.
But before those claims make it onto a product label or website, there’s an important question to answer: Does the research actually support what the brand wants to say?
Finding a published study is a good starting point, but the details of that research matter. A study might demonstrate benefits at a higher dosage than the finished product contains. It might involve participants with a particular health condition, while the supplement is intended for generally healthy adults. Or the researchers may have measured an outcome that differs from the benefit the brand wants to advertise.
Consider a supplement brand preparing to launch a joint health product. The brand has finalized packaging and marketing materials around claims of improved joint mobility and flexibility. During a final regulatory review, however, the supporting research is found to involve a different ingredient dosage and a population that does not adequately represent the product’s intended customers.
The distinction matters because supplement claims shape what consumers expect a product to do. Statements on packaging, product pages, advertisements, and other marketing materials need to accurately reflect the benefits supported by the available evidence.
Evaluating the research early in product development helps brands determine which benefits they can reasonably communicate, whether their formulation aligns with the evidence, and where additional support may be needed.
The first step is understanding exactly what a product claim communicates.
Understanding What Your Product Claim Communicates
The wording of a supplement claim can significantly change what consumers expect from a product. Even small differences in language can turn a general statement about supporting normal bodily functions into a promise of a specific, measurable result.
For example, a supplement marketed as supporting healthy cognitive function communicates a different benefit than one claiming to improve memory within 30 days. The second statement promises a particular outcome within a defined timeframe, which requires evidence that adequately supports both.
The FDA and FTC also have different responsibilities when it comes to supplement claims.
The FDA oversees dietary supplement labeling, including structure/function claims that describe how an ingredient or product supports normal bodily functions. These claims must be truthful and not misleading, and applicable structure/function claims require substantiation, a disclaimer, and notification to the FDA. Claims that a dietary supplement diagnoses, treats, cures, or prevents a disease are generally prohibited.
The FTC focuses on advertising and whether the claims communicated to consumers are supported by competent and reliable scientific evidence. Its standards apply to both explicit statements and benefits implied through marketing.
That means brands need to consider more than the words printed on a label. Product imagery, customer testimonials, before-and-after photographs, and surrounding marketing language can influence how consumers interpret a claim. A carefully worded statement may still communicate an unsupported benefit when presented alongside other promotional elements.
“Every product claim sets an expectation with the customer. If the science doesn't support that expectation, the brand risks losing credibility before the product has a chance to prove itself. That's why claim substantiation needs to be part of the marketing strategy from the beginning.”
Tiffany Chang, Director of Strategic Marketing, Next Day Nutra
Consider a supplement advertised as supporting healthy joints. If its marketing also features testimonials describing relief from arthritis symptoms, consumers may reasonably interpret the overall message as a claim about treating a medical condition, even if the product description never explicitly makes that promise.
Understanding these distinctions helps brands evaluate what their marketing materials are communicating and identify the scientific evidence needed to support those messages.
What Makes Scientific Evidence Strong Enough to Support a Claim?
Not all scientific studies provide the same level of support for a supplement claim. When evaluating research, brands need to look beyond whether a study reported positive results and consider how the research was conducted, what it measured, and whether its findings apply to the product being developed.
Human clinical trials are generally among the strongest forms of evidence for health-related claims, particularly when participants are randomly assigned to treatment and control groups. However, even a well-designed trial may offer limited support if the conditions of the study differ significantly from how the supplement will be marketed or used.
The study population is one important consideration. Research involving older adults, people with a specific nutritional deficiency, or individuals with a diagnosed condition may produce results that do not necessarily apply to generally healthy consumers. Brands should also examine the dosage administered, how long participants took the ingredient, and whether the researchers measured the same benefit the brand intends to communicate.
Consider a hypothetical clinical trial in which participants experienced measurable improvements after taking 500 mg of an ingredient daily for 12 weeks. If a supplement brand includes only 100 mg of that ingredient in its formulation and advertises similar improvements within 30 days, the original study would not directly support those claims. The dosage, duration, and expected results no longer align with the research.
Real-world advertising challenges demonstrate why these distinctions matter.
In 2025, OLLY faced an advertising challenge involving its Kids Chillax supplement, which was marketed as supporting a calm and relaxed mood in children. Although OLLY submitted a clinical study of the finished product and additional research on L-theanine, the National Advertising Division (NAD) determined that the evidence did not adequately support the advertised benefits. Among its concerns were the reliability of the methods used to assess anxiety in younger participants and whether the research supported the specific claims being made. The case illustrates why even clinical research conducted on a finished product must be carefully evaluated against the benefits a brand intends to advertise.
Brands also need to consider the research as a whole. A single positive study may be less persuasive when other well-designed studies have produced conflicting or inconclusive results. The consistency of findings, quality of the research, and limitations of individual studies all influence how confidently a benefit can be communicated.
Importantly, this does not mean every supplement claim requires a new clinical trial. Certain claims about the established functions of essential nutrients may be supported by a substantial body of existing scientific knowledge.
For example, calcium’s role in maintaining normal bone health is well documented. A brand making an appropriately worded claim about that established function may be able to rely on existing research rather than conducting a new trial.
These considerations become particularly important when brands rely on research involving individual ingredients to support claims about a finished supplement containing multiple ingredients.
When Ingredient Research Doesn’t Match the Finished Product
Supplement brands frequently rely on clinical research involving individual ingredients when developing new formulations. This research can provide valuable insight into an ingredient’s potential benefits, but the finished supplement may differ considerably from what researchers actually studied.
Dosage is one of the most common differences. An ingredient may have demonstrated benefits in clinical research, but those findings may not apply when the finished supplement contains a substantially lower amount. Without additional supporting evidence, the brand cannot assume consumers will experience the same results.
These differences can emerge during formulation development. A brand may begin with several clinically studied ingredients, then adjust their amounts to meet a target price, serving size, or capsule count. Each adjustment may be commercially reasonable, but it can also change how closely the finished product aligns with the research supporting its intended benefits.
Ingredient form and delivery method can introduce additional considerations. Research involving a specific standardized botanical extract may not apply equally to a different extract or an unstandardized powder from the same plant. Similarly, studies using a particular chemical form of a nutrient may not establish equivalent effects for every other form.
Combination formulas introduce another layer of complexity. A supplement containing five ingredients may have research supporting each ingredient individually, but that doesn’t necessarily establish how the complete formula will perform. The ingredients may have been studied at different dosages, in different populations, or for different outcomes. Combining them into one product does not automatically demonstrate that their individual benefits will occur together or produce a greater overall effect.
Consider a supplement formulated to support sleep quality. Its ingredients may include magnesium, L-theanine, and a botanical extract, each selected based on existing research. However, if the studies examined those ingredients separately, the brand needs to be careful about claiming that the finished combination produces specific improvements in sleep duration or quality. Those outcomes would need adequate scientific support for the product and claims being marketed.
For brands developing supplements, this creates an important connection between formulation decisions and marketing strategy. Research may help identify promising ingredients, but the amounts, forms, and combinations ultimately selected determine how relevant that research remains.
A formulation can be technically feasible, commercially attractive, and built around well-researched ingredients while still lacking adequate support for its intended marketing claims. Identifying those gaps during development gives brands an opportunity to adjust the formula or reconsider the claims before committing to packaging and promotional materials.
Why Claims Should Be Evaluated Before Packaging and Marketing
By the time a supplement brand begins designing its packaging, product claims often feel like an established part of the product. They influence the product name, label design, website copy, advertising strategy, and even how the sales team introduces the supplement to potential customers.
If those claims haven’t been adequately substantiated, the brand may be building its launch around benefits it cannot confidently communicate.
Consider a supplement developed around an ingredient associated with cognitive performance. The brand positions the product as improving memory and concentration, incorporates those benefits into its packaging, and prepares a marketing campaign around measurable improvements. During a final regulatory review, however, the supporting research is found to establish only a more general role in normal cognitive function.
The brand now faces a difficult decision. It may need to revise its claims, obtain additional supporting evidence, or reconsider the formulation itself. Each option can affect the launch timeline, development budget, and marketing strategy.
Packaging changes can be particularly costly once production is underway. Printed labels, cartons, and other branded materials may need to be revised or discarded. Product photography, website content, advertisements, and retailer listings may also require updates to reflect the revised positioning. If inventory has already been produced, the consequences can extend into warehousing, distribution, and launch scheduling.
These costs are easier to avoid when scientific substantiation is considered alongside formulation development rather than treated as a final approval step.
Early claim evaluation also gives product development and marketing teams a clearer understanding of what the supplement can reasonably promise. If research supports a particular benefit only at a specific dosage, that information can guide formulation decisions before ingredient costs and serving sizes are finalized. If the available evidence supports a narrower benefit than originally envisioned, the brand can adjust its positioning while there is still flexibility to do so.
This approach becomes especially valuable as brands expand their product portfolios. Each new supplement introduces its own formulation, supporting research, and marketing claims. Establishing a consistent process for evaluating those claims helps prevent avoidable revisions while giving teams a stronger foundation for product development.
Ultimately, the timing of claim substantiation influences more than regulatory compliance. It affects how efficiently a supplement moves from concept to market, how confidently the brand can communicate its benefits, and how much flexibility remains when scientific evidence calls for a change in direction.
Building a More Defensible Approach to Supplement Claims
Developing substantiated supplement claims requires coordination between scientific research, formulation, regulatory review, and marketing. When these decisions are made independently, brands risk developing products whose advertised benefits extend beyond what the available evidence can support.
A more reliable approach begins by identifying the benefits a product is intended to deliver and examining the research behind them. This allows brands to evaluate whether the proposed ingredients, dosages, and formulation are consistent with the scientific findings before making significant development commitments.
As the formula takes shape, brands should maintain a clear record of their proposed claims and the evidence supporting each one. This documentation should identify the relevant studies, explain how their findings apply to the finished product, and account for important limitations or conflicting research. Keeping this information organized gives product development, regulatory, and marketing teams a consistent basis for reviewing claims as formulations and promotional materials evolve.
For supplement brands working with formulation and manufacturing partners, these discussions are most valuable when they happen early. A manufacturer may help identify ingredient options, practical dosage ranges, and formulation constraints, while qualified scientific and regulatory professionals assess whether the available evidence adequately supports the proposed claims. Bringing these perspectives together can help brands make informed decisions before investing in packaging, inventory, and launch campaigns.
A published study can provide a valuable starting point for product development, but the strength of a supplement claim depends on how well the research supports the benefit consumers are being promised. Brands that establish this connection early are better positioned to develop credible products, communicate their benefits accurately, and avoid costly changes later in the process.
Next Day Nutra works with supplement brands to align formulation and manufacturing decisions with their product development goals. If you’re developing a new supplement or evaluating an existing formulation, our team can help you explore the options available for bringing your product to market.
Industries
Recent Posts
